Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001391 |
---|---|
Receipt number | R000001563 |
Scientific Title | An open-label, randomized, controlled trial to assess the efficacy and safety of teprenone in chronic hepatitis C patients concurrent with chronic gastritis treated with peginterferon alpha-2b plus ribavirin. |
Date of disclosure of the study information | 2009/03/01 |
Last modified on | 2021/04/23 15:53:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/09/24 23:08:12 | ||
2 | Update | 2009/02/14 09:36:06 | Date of disclosure of the study information |
|
3 | Update | 2010/09/24 09:07:56 | Recruitment status Last follow-up date |
|
4 | Update | 2011/04/24 09:23:40 | Organization Address Organization Organization Address Address Institute Organization1 Address1 |
|
5 | Update | 2011/04/24 09:25:06 | Last follow-up date |
|
6 | Update | 2012/04/24 13:44:04 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2012/04/24 13:44:19 | Recruitment status |
|
8 | Update | 2012/09/24 09:20:06 | Publication of results |
|
9 | Update | 2013/09/24 22:37:16 | TEL Address Address TEL |
|
10 | Update | 2018/10/02 09:35:34 | Name of primary person or sponsor Organization |
|
11 | Update | 2019/04/03 13:25:38 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
12 | Update | 2021/04/23 15:53:42 | Recruitment status Date of IRB Last follow-up date |